These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3339748)

  • 1. Ejaculatory failure and urinary dysfunction secondary to labetalol.
    O'Meara J; White WB
    J Urol; 1988 Feb; 139(2):371-2. PubMed ID: 3339748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone-associated ejaculatory and urinary dysfunction in male adolescents.
    Holtmann M; Gerstner S; Schmidt MH
    J Child Adolesc Psychopharmacol; 2003; 13(1):107-9. PubMed ID: 12804132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Side-effects with long-term labetalol: an open study of 251 patients in a single centre.
    Tcherdakoff P
    Pharmatherapeutica; 1983; 3(5):342-8. PubMed ID: 6844370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone-induced ejaculatory and urinary dysfunction.
    Madhusoodanan S; Brenner R
    J Clin Psychiatry; 1996 Nov; 57(11):549-50. PubMed ID: 8968309
    [No Abstract]   [Full Text] [Related]  

  • 5. Scalp tingling and difficulty in micturition in patients on labetalol.
    Bailey RR
    Lancet; 1977 Oct; 2(8040):720-1. PubMed ID: 71532
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypertension with labetalol.
    Bolli P; Waal-Manning HJ; Simpson FO; Seeman HM
    N Z Med J; 1977 Dec; 86(602):557-63. PubMed ID: 306082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol: an alpha- and beta-adrenoceptor blocking drug.
    Michelson EL; Frishman WH
    Ann Intern Med; 1983 Oct; 99(4):553-5. PubMed ID: 6137987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction.
    Rosen RC; Catania JA; Althof SE; Pollack LM; O'Leary M; Seftel AD; Coon DW
    Urology; 2007 May; 69(5):805-9. PubMed ID: 17482908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular failure with labetalol.
    Frais MA; Bayley TJ
    Postgrad Med J; 1979 Sep; 55(646):567-8. PubMed ID: 514938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot trial of labetalol (AH 5158A): a combined alpha and beta blocker in treatment of hypertension.
    Dent R; Kellaway GS
    N Z Med J; 1977 Sep; 86(595):213-5. PubMed ID: 305013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ergometric control in hypertension treatment with labetalol].
    Prohaska H; Honetz N
    Wien Med Wochenschr Suppl; 1981; 69():20-2. PubMed ID: 6952661
    [No Abstract]   [Full Text] [Related]  

  • 15. [Negative effects on sexual function of medications for the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; de La Taille A; Giuliano F; Desgrandchamps F; Doridot G
    Prog Urol; 2015 Mar; 25(3):115-27. PubMed ID: 25605342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Labetalol-induced hepatitis in a patient with chronic hepatitis B infection.
    Marinella MA
    J Clin Hypertens (Greenwich); 2002; 4(2):120-1. PubMed ID: 11927791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol in long-term treatment of hypertension.
    Prichard BN; Boakes AJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial.
    Brookes ST; Donovan JL; Peters TJ; Abrams P; Neal DE
    BMJ; 2002 May; 324(7345):1059-61. PubMed ID: 11991908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of alpha(1)-adrenoceptor antagonists on male sexual function.
    van Dijk MM; de la Rosette JJ; Michel MC
    Drugs; 2006; 66(3):287-301. PubMed ID: 16526818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction.
    Karabakan M; Keskin E; Akdemir S; Bozkurt A
    Int Braz J Urol; 2017; 43(2):317-324. PubMed ID: 27819758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.